To further explore the effects of CHML knockout on the occurrence and progression of liver cancer, we conducted a joint analysis of DEGs via transcriptomic sequencing and differentially metabolized compounds based on untargeted metabolomics. This evidence concerns the gene CHML and liver cancer.